Altimmune, Inc.ALTNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P77
Within normal range
vs 2Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 7.69% |
| Q3 2025 | 4.80% |
| Q2 2025 | 5.25% |
| Q1 2025 | 8.57% |
| Q4 2024 | -7.63% |
| Q3 2024 | -12.75% |
| Q2 2024 | -11.95% |
| Q1 2024 | -26.69% |
| Q4 2023 | 18.82% |
| Q3 2023 | -15.24% |
| Q2 2023 | -1.13% |
| Q1 2023 | -9.66% |
| Q4 2022 | -11.50% |
| Q3 2022 | 2.19% |
| Q2 2022 | -2.60% |
| Q1 2022 | -11.94% |
| Q4 2021 | -5.60% |
| Q3 2021 | -13.30% |
| Q2 2021 | -7.87% |
| Q1 2021 | 9.10% |
| Q4 2020 | -4.36% |
| Q3 2020 | 36.50% |
| Q2 2020 | 60.34% |
| Q1 2020 | -8.30% |
| Q4 2019 | -9.58% |
| Q3 2019 | -21.93% |
| Q2 2019 | -31.49% |
| Q1 2019 | 17.46% |
| Q4 2018 | -82.28% |
| Q3 2018 | -19.82% |
| Q2 2018 | -45.50% |
| Q1 2018 | -5.20% |
| Q4 2017 | -23.16% |
| Q3 2017 | -49.32% |
| Q2 2017 | 137.77% |
| Q1 2017 | -7.82% |
| Q4 2016 | -85.65% |
| Q3 2016 | 462.34% |
| Q2 2016 | 44.62% |
| Q1 2016 | -6.19% |